Estimada Dra. Falt y demás colegas:
Las vacunas que se comercializan en el mercado argentino están elaboradas con virus parvo de las cepas 2a y 2b.
Según una publicación americana de septiembre de 2008 (que creo envió el Dr. Mauro al foro), un perro con un buen plan vacunal no debería enfermar si se enfrentara al parvo 2c:
"Q: Is there a vaccine for CPV-2c?
A: Although there is no vaccine to specifically prevent CPV-2c infection, studies have shown that all of the currently available vaccines produced by the five major vaccine manufacturers (Fort Dodge Animal Health, Intervet, Merial, Pfizer and Schering-Plough), when administered appropriately, provide excellent immunity to all variants of the canine parvovirus.
Puppies should receive a dose of canine parvovirus vaccine between 14 and 16 weeks of age, regardless of how many doses they received earlier, to develop adequate protection."
Les envío saludos cordiales.
Dr. César Cañizares Van Brussel